News and events

Targeting turncoat immune cells to treat cancer Published at 18.02.20
Targeting turncoat immune cells to treat cancer
Research led by Ping-Chih Ho of the Ludwig Lausanne branch has identified a mechanism by which regulatory T cells adapt their metabolism to thrive in the harsh microenvironment of the tumor.
Countering therapy resistance in colorectal cancer Published at 05.02.20
Countering therapy resistance in colorectal cancer
A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL.
Building a safer CAR-T therapy Published at 04.02.20
Building a safer CAR-T therapy
A new type of chimeric antigen-receptor (CAR) T cell that can be switched on and off on demand is unveiled in a study led by Melita Irving and George Coukos, both of the Lausanne Branch of the Ludwig Institute for Cancer Research, and Bruno Correia of the EPFL.
Johanna Joyce in Nature Cancer on the TME Published at 15.01.20
Johanna Joyce in Nature Cancer on the TME
Nature Cancer's launch issue invites ten researchers, amongst whom Johanna Joyce, to draw out a roadmap for the next decade in cancer research.

Link to the news archives

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
ludwig_cancer_research-logo.svg universite_de_lausanne-logo.svg chuv-logo.svg